Analysts are expecting stock price gains for the vast majority of insurance underwriters and insurance brokers over the next year. Of 58 insurance companies surveyed in this analysis, 50 are trading below analysts' one-year mean price targets, and 13 are expected to post gains of 20% or more.
Ambac Financial Group Inc. is trading 59.9% below its mean one-year price target, the largest discount of any stock in the analysis. Over the last year, Ambac's stock has lost 25.2% of its value, but two out of three covering analysts recommend buying the stock.
EHealth Inc. had the second-highest implied upside at 51%, despite already booking significant gains. It recorded a 44.2% return over the past year.
Even after a 110.5% gain over the past year, analysts still think Health Insurance Innovations Inc. has an additional 45.9% upside over the next 12 months. All eight covering analysts recommend buying the stock.
On the other hand, insurance underwriter RLI Corp. is trading 13.4% above its mean one-year price target, the most of any company in the analysis. Although its shares have returned 14.4% over the last year, none of the six covering analysts recommend buying the stock.
In this analysis, S&P Global Market Intelligence examined major exchange-traded U.S. insurance underwriters and insurance brokers trading in relation to mean one-year analyst price targets as of March 12. Only stocks covered by at least three analysts and trading above $5 per share were included in this analysis.

